Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Cefpodoxime & Potassium Clavulanate Tablets bulk supplier for pharma manufacturers

Cefpodoxime & Potassium Clavulanate Tablets 325mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 325mg

Reference Brands: -

Category: Antibiotics

The salt combination Cefpodoxime / Clavulanic Acid is used for the treatment of Bacterial Infections, Urinary Tract Infection, Gonorrhea, Pneumonia, Pyelonephritis, Sinusitis and other conditions.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Cefpodoxime & Potassium Clavulanate Tablets? List it or send an offer →

Product Description: Cefpodoxime / Clavulanic Acid is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Bacterial Infections · Urinary Tract Infection · Gonorrhea · Pneumonia · Pyelonephritis · Sinusitis · Infections After Surgery

Cefpodoxime & Potassium Clavulanate Tablets — third party manufacturing & bulk supply

Cefpodoxime & Potassium Clavulanate Tablets 325mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Cefpodoxime & Potassium Clavulanate Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Cefpodoxime & Potassium Clavulanate Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Cefpodoxime & Potassium Clavulanate Tabl... →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Cefpodoxime & Potassium Clavulanate Tablets is listed as Tablets in 325mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Cefpodoxime & Potassium Clavulanate Tablets is referenced against -. Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Cefpodoxime Proxetil Tablets

Strength:
50 mg, 100 mg, 200 mg

Form: Tablets

Reference Brands: Vantin (US), Orelox (EU)

View Details
Cefixime Tablets

Strength:
100 mg, 200 mg

Form: Tablets

Reference Brands: -

View Details
Cefuroxime & Potassium Clavulanate Tablets

Strength:
625 mg, 312.5 mg , 156.25 mg

Form: Tablets

Reference Brands: -

View Details
Cefixime / Ofloxacin Tablets

Strength:
200mg + 200mg

Form: Tablets

Reference Brands: -

View Details
Amikacin 500 mg Injectable Solution

Strength:
250 mg/2 mL, 500 mg/2 mL, 1 g/2 mL

Form: Injectable Solution

Reference Brands: Amikin(Us & EU)

View Details
Amikacin Inhalation Solution

Strength:
25 mg/2 mL, 50 mg/2 mL

Form: Inhalation Solution

Reference Brands: -

View Details
Tobramycin Injectable (IV, IM)

Strength:
10 mg/mL, 40 mg/mL, 80 mg/mL

Form: Injectable (IV, IM)

Reference Brands: -

View Details
Tobramycin Inhalation Solution

Strength:
300 mg/5 mL

Form: Inhalation Solution

Reference Brands: Tobi (US)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us